|
KMID : 1144120210110030217
|
|
Biomedical Engineering Letters
2021 Volume.11 No. 3 p.217 ~ p.233
|
|
|
Challenges in delivery systems for CRISPR-based genome editing and opportunities of nanomedicine
|
|
Sioson Victor Aaron
Kim Min-Jong
Joo Jin-Myoung
|
|
|
Abstract
|
|
|
|
The CRISPR-based genome editing technology has opened extremely useful strategies in biological research and clinical therapeutics, thus attracting great attention with tremendous progress in the past decade. Despite its robust potential in personalized and precision medicine, the CRISPR-based gene editing has been limited by inefficient in vivo delivery to the target cells and by safety concerns of viral vectors for clinical setting. In this review, recent advances in tailored nanoparticles as a means of non-viral delivery vector for CRISPR/Cas systems are thoroughly discussed. Unique characteristics of the nanoparticles including controllable size, surface tunability, and low immune response lead considerable potential of CRISPR-based gene editing as a translational medicine. We will present an overall view on essential elements in CRISPR/Cas systems and the nanoparticle-based delivery carriers including advantages and challenges. Perspectives to advance the current limitations are also discussed toward bench-to-bedside translation in engineering aspects.
|
|
|
KEYWORD
|
|
|
CRISPR, Nanoparticle, Gene editing, Drug delivery, Gene theray
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|